AdaptHealth
AHCO· Services· Fiscal year ends in December
CEO pay in FY2024Stock +30.6% in FY2024
Suzanne Foster is the CEO of AdaptHealth and was paid $8.4M in FY2024 (Dec).
Pay$100 in the stock at the end of FY21 → $39
Executives5
See all- 1Suzanne FosterChief Executive OfficerFY2024
- 2Jason ClemensChief Financial OfficerFY2025
- 3Toby Scott BarnhartChief Operating OfficerFY2025
- 4Russell SchusterChief Commercial OfficerFY2025
- 5Albert PrastChief Technology OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allAdaptHealth paid its 4 named executives $13.7M in total in FY2025 (Dec).
| Name | |||
|---|---|---|---|
| Jason ClemensChief Financial Officer | |||
| Toby Scott BarnhartChief Operating Officer | |||
| Russell SchusterChief Commercial Officer | |||
| Albert PrastChief Technology Officer | |||
| Suzanne FosterChief Executive Officer | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for AdaptHealth. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Board5
See all- Dale B. WolfChair · 6 yr on the boardIndependentAudit—Paid as an executive
- Brad CoppensDirector · 5 yr on the boardIndependentAudit, Compensation (Chair)—Paid as an executive
- David S. Williams IIIDirector · 5 yr on the boardIndependentCompensation, Corporate Compliance and Governance—Paid as an executive
- Ted LundbergDirector · 4 yr on the boardIndependentAudit, Corporate Compliance and Governance (Chair)—Paid as an executive
- Suzanne FosterDirector · 1 yr on the boardNot independentAudit—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 28, 2026 | FY2025 |
| Annual report | 10-K | Feb 24, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 30, 2025 | FY2024 |
| Annual report | 10-K | Feb 25, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 26, 2024 | FY2023 |
| Annual report | 10-K | Feb 27, 2024 | FY2023 |
